A Type 1 diabetes intelligence desk with research, device, and care-planning materials.
Type1Cure original generated editorial image / Project-owned generated asset
Daily Briefing/June 13, 2026/3 min read

June 13, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

daily briefingtype 1 diabetestrialsdevice safetyresearch

The short version

The June 13, 2026 feed is strongest in three lanes: device safety, recruiting studies, and recent research records. Type1Cure treats safety and trial records as higher-priority signals because they can affect what a family may need to check, ask, or watch next.

This is not a medical recommendation. It is a source map and plain-English triage layer designed to help families decide what deserves a closer look with their care team.

Signals in the feed

  • French Prospective Multicentric Study in Real World — RECRUITING. Interventions: Omnipod 5. Locations: Angers, France | Besançon, France | Bobigny, France. The purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life,...Source
  • Type 1 Diabetes Adolescents for Healthier Lifestyles Study — RECRUITING, NA. Interventions: T1DAL Program. Locations: Providence, Rhode Island, United States. Before the 1990s, obesity was rare among young people with type 1 diabetes (T1D), but now it is more common. Recent studi...Source
  • Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App Model/Catalog Number: SW12300 Software Version: Versions 2.9.0 through 2.11.2 Produc... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...Source
  • Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App Model/Catalog Number: SW13355 Software Version: Versions 2.9.0 through 2.11.2 Pr... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...Source
  • Dexcom, Inc.: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App Model/Catalog Number: SW14244 Software Version: versions 1.5.0 and 1.6.0 Product... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...Source
  • Prebiotics in Patients With Type 1 Diabetes — RECRUITING, NA. Interventions: Prebiotic, Placebo. Locations: Calgary, Alberta, Canada | Edmonton, Alberta, Canada | Saskatoon, Saskatchewan, Canada. Evidence suggests that prebiotic fibre can correct dysbiosis, reduce...Source
  • North American Rescue LLC.: AIDBAGs are first aid kits of convenience composed of individually labeled devices designed as specialty first aid kits designed for the appropriate level provider to evaluate and... — Kits contain the McKesson TRUE Metrix PRO Professional Monitoring Blood Glucose System that has been recalled for an issue with the software design of the E-5 Error Code where the meter displays an E-5 error code for a...Source

How to use this briefing

Start with the evidence label. Official registry and regulator records are not the same thing as advice, but they are stronger source material than a repost, rumor, or promotional headline.

For trials, check eligibility, location, burden, intervention, and contact details at the original registry. For device safety, check exact product names, models, lot numbers, software versions, and manufacturer instructions.

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.